Chengdu Zenitar Biomedical Technology Co., Ltd

This study is testing whether a new oral drug called ZL-82 can help control moderate to severe atopic dermatitis (eczema) in adults. About 111 participants will take either ZL-82 or a placebo pill daily for 16 weeks to see if it reduces the severity of their skin rash and itching…

This study is testing whether a new injectable drug called Purinostat mesylate works better than the existing oral drug selinexor for adults with a fast-growing type of lymphoma that has come back or hasn't responded to prior treatments. About 390 participants will be randomly as…

This study is testing whether a new tablet called flonoltinib maleate can help people with intermediate- or high-risk myelofibrosis, a serious bone marrow cancer. About 105 participants will take either the new drug or an existing treatment to see which one better reduces spleen …

This study is testing an experimental pill called flonoltinib for adults with polycythemia vera (PV), a rare blood cancer, whose disease doesn't respond well to or who can't tolerate standard medications. The main goal is to see if different doses of the drug can safely control b…